Related Experiment Video
Updated: Jun 25, 2026

Author Spotlight: Unlocking the Mysteries of Oral Potential Malignancies
Published on: August 11, 2023
Systematic Analysis of Multiple Imaging Modalities in Infants Diagnosed with Mucopolysaccharidosis by Newborn
Chung-Lin Lee1,2,3,4,5, Szu-Wen Chang1, Hung-Hsiang Fang1,6
1Department of Pediatrics, MacKay Memorial Hospital, Taipei 10449, Taiwan.
Insights
Newborn screening detects mucopolysaccharidosis (MPS) abnormalities before symptoms appear. Comprehensive imaging and biochemical marker correlations aid early diagnosis and monitoring of these rare genetic disorders.
Area of Science:
- Medical Genetics
- Pediatric Radiology
- Lysosomal Storage Disorders
Background:
- Mucopolysaccharidosis (MPS) comprises progressive genetic disorders impacting multiple organ systems.
- Early detection via newborn screening is crucial, yet pre-symptomatic imaging assessment is not well-defined.
- This study focuses on identifying early imaging markers in screen-positive infants.
Purpose of the Study:
- To analyze skeletal, cardiac, and abdominal imaging findings in infants diagnosed with MPS via newborn screening.
- To establish an integrated imaging assessment model for early-stage MPS.
- To correlate imaging findings with biochemical markers for enhanced diagnostic insights.
Main Methods:
- Retrospective analysis of 277 screen-positive MPS cases (MPS I, II, IVA, VI) from 2015-2024.
- Standardized skeletal radiography, cardiac, and abdominal ultrasonography were performed.
- Imaging data were analyzed alongside biochemical markers and clinical parameters.
Main Results:
- Cardiac abnormalities (e.g., ASD/PFO) were most frequent in MPS I (33.3%).
- Vertebral changes were more common in MPS IVA (16.5%) and MPS II (15.9%).
- Significant correlations found between vertebral issues and keratan sulfate, cardiac issues and dermatan sulfate, and abdominal findings and enzyme activity/DBU ratios.
Conclusions:
- Significant presymptomatic abnormalities in MPS infants can be detected through comprehensive imaging.
- Correlations between imaging and biochemical markers offer novel insights for early diagnosis and monitoring.
- Implementing integrated imaging protocols for screen-positive cases is recommended.
Abstract:
Background/Objectives: Mucopolysaccharidosis (MPS) is a group of progressive lysosomal storage disorders affecting multiple organ systems. Although newborn screening enables early detection, early comprehensive imaging assessment during pre-symptomatic stages remains poorly understood. This study analyzed skeletal radiographic and cardiac and abdominal ultrasonographic findings in infants diagnosed by newborn screening to establish an integrated imaging assessment model. Methods: This retrospective study examined 277 screen-positive cases (15 MPS I, 113 MPS II, 127 MPS IVA, and 22 MPS VI) identified through newborn screening between 2015 and 2024. All patients underwent standardized skeletal radiography and cardiac and abdominal ultrasonography. Imaging findings were analyzed in conjunction with biochemical markers and clinical parameters. Results: Cardiac abnormalities were most prevalent in MPS I (33.3% ASD/PFO), whereas vertebral changes were more common in MPS IVA (16.5%) and MPS II (15.9%). We observed a number of significant correlations: vertebral abnormalities correlated with keratan sulfate levels, cardiac manifestations with dermatan sulfate levels, and abdominal findings with enzyme activity levels and urinary dimethylene blue ratios. Conclusions: This systematic analysis of multiple imaging modalities in infants diagnosed with MPS by newborn screening demonstrates that significant abnormalities can be detected during the presymptomatic stage. Correlations between imaging findings and biochemical markers provide new insights for early diagnosis and monitoring, and support implementing comprehensive imaging protocols during the initial screen-positive cases evaluation.
More Related Videos
Related Concept Videos
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Introduction
Hyperglycemia

